Picture of Immutep logo

IMM — Immutep Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Annual cashflow statement for Immutep, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital3.614.667.667.926.59
Other Operating Cash Flow
Cash from Operating Activities-30.2-35.4-34.8-62-55.5
Capital Expenditures-0.023-0.083-0.932-0.271-0.093
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items——-20.1-38.356.6
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.023-0.083-21-38.556.5
Financing Cash Flow Items-2.43-3.85-4.83-0.2540
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities50.37695.2-0.525-0.214
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash19.443.438.4-94.4-3.74